Skip to main content
Loading ResearchHub…
References for Systemic inflammation and prognosis in patients with RAS / BRAF wild‐type metastatic colorectal cancer receiving anti‐ EGFR therapy: A real‐world cohort study | ResearchHub - ResearchHub